This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: Boundless Bio, Inc.. Active years: 2023-2026.
Company Filing History:
Years Active: 2023-2026
Title: Jacques Mauger: Innovator in Cancer Treatment
Introduction
Jacques Mauger is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds.
Latest Patents
Mauger holds a patent for Checkpoint kinase 1 (CHK1) inhibitors and their uses. This patent outlines compounds and methods for treating cancer, specifically detailing the administration of a therapeutically effective amount of a Chk1 inhibitor to subjects in need.
Career Highlights
Jacques Mauger is currently associated with Boundless Bio, Inc., where he continues to advance his research in oncology. His work focuses on developing novel therapeutic strategies to combat cancer effectively.
Collaborations
Mauger collaborates with notable colleagues, including Anthony B. Pinkerton and Stephen Todd Meyer, who contribute to his research endeavors.
Conclusion
Jacques Mauger's innovative work in developing CHK1 inhibitors represents a significant advancement in cancer treatment, showcasing his dedication to improving patient outcomes.